Clorox sees GOJO Industries acquisition accretive to adjusted EPS in year two

The transaction is expected to accelerate the financial performance of the company and create long-term shareholder value. Contributes a recurring revenue and stable earnings base to Clorox (CLX); Accretive to growth and supports Clorox’s long-term sales growth target of 3-5%; Poised to generate at least $50M in run-rate cost synergies, leveraging Clorox’s scale and holistic margin management capabilities; Accretive to Clorox’s adjusted EBITDA margins after realization of run-rate cost synergies, neutral in the first year; Accretive to Clorox’s adjusted EPS in the second year; neutral in the first year